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Pulmonary vein (PV) triggers play a major role in the ini-tiation of atrial fibrillation (AF), and PV isolation (PVI) 
is the cornerstone of catheter ablation for AF. Although this 
strategy is effective in patients with paroxysmal AF, the 
success rate is limited in nonparoxysmal forms of AF. It is 
generally thought that early in the course of AF, triggers pre-
dominate. As the arrhythmia becomes more established, the 
sustained high rates in the atrium or the presence of under-
lying heart disease induce alterations in the underlying sub-
strate that promote AF perpetuation (“AF begets AF”).1 This 
has led to the development of adjunctive substrate modifica-
tion strategies to improve persistent AF ablation.2,3 However, 
the mechanisms underlying AF persistence are not uniform. 
A trigger-based mechanism may be operative in a subset of 
patients as demonstrated by the impact of strategies target-
ing triggers reinitiating AF immediately after cardioversion.4,5 
The challenge, however, still remains to identify such patients 
to allow individual-specific tailoring of the ablation strategy.
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Background—Rapid pulmonary vein (PV) activity has been shown to maintain paroxysmal atrial fibrillation (AF). We 
evaluated in persistent AF the cycle length (CL) gradient between PVs and the left atrium (LA) in an attempt to identify 
the subset of patients where PVs play an important role.
Methods and Results—Ninety-seven consecutive patients undergoing first ablation for persistent AF were studied. For each 
PV, the CL of the fastest activation was assessed over 1 minute (PVfast) using Lasso recordings. The PV to LA CL gradient 
was quantified by the ratio of PVfast to LA appendage (LAA) AF CL. Stepwise ablation terminated AF in 73 patients 
(75%). In the AF termination group, the PVfast CL was much shorter than the LAA CL resulting in lower PVfast/LAA 
ratios compared with the nontermination group (71±10% versus 92±7%; P<0.001). Within the termination group, PVfast/
LAA ratios were notably lower if AF terminated after PV isolation or limited adjunctive substrate ablation compared with 
patients who required moderate or extensive ablation (63±6% versus 75±8%; P<0.001). PVfast/LAA ratio <69% predicted 
AF termination after PV isolation or limited substrate ablation with 74% positive predictive value and 95% negative 
predictive value. After a mean follow-up of 29±17 months, freedom from arrhythmia recurrence off-antiarrhythmic drugs 
was achieved in most patients with PVfast/LAA ratios <69% as opposed to the remaining population (80% versus 43%; 
P<0.001).
Conclusions—The PV to LA CL gradient may identify the subset of patients in whom persistent AF is likely to terminate after 
PV isolation or limited substrate ablation and better long-term outcomes are achieved.  (Circ Arrhythm Electrophysiol. 
2014;7:473-482.)
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Previous clinical studies have demonstrated that intermit-
tent rapid rhythms arising in the PVs are commonly observed 
during sustained episodes of paroxysmal AF. These rapid 
activities were identified when the cycle length (CL) recorded 
inside the PV was shorter than the AF CL recorded in the adja-
cent left atrium (LA)6 or when a clustering of shorter CL was 
observed on the plotted frequency histogram of the PV activ-
ity.7 These studies demonstrated that intermittent rapid PV 
rhythms represent an active phenomenon that may have a crit-
ical role in the maintenance of AF by providing a continued 
refueling of the fibrillatory process.6–9 Whether the identifica-
tion of such PV activities can help characterize the contribu-
tion of PVs in the maintenance of persistent AF has not been 
addressed. We hypothesized that a high gradient between the 
CL of PV activity and the LA AF CL would identify patients 
where PVs play an important role, whereas the absence of 
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such a gradient would point toward passive PV activity. We, 
therefore, aimed to evaluate if this CL gradient would predict 
(1) procedural AF termination, (2) AF termination with PVI 
only, and (3) postablation clinical success.
Methods
Study Population
The study population consisted of consecutive patients who underwent 
first-time catheter ablation for symptomatic drug-refractory persistent 
AF. AF was defined as persistent (sustained >7 days or lasting <7 days 
but necessitating cardioversion) or long-lasting persistent (continuous 
AF of >1 year duration). All patients were in AF spontaneously at the 
beginning of the procedure and had PV mapping with a circumferential 
catheter before ablation. To evaluate the contribution of PV activity to 
the maintenance of AF, only patients in whom isolation of all PVs was 
completed before starting substrate-based ablation were included.
All patients provided written informed consent.
Electrophysiological Study
Antiarrhythmic medication was discontinued ≥5 half-lives before ab-
lation, with the exception of amiodarone. Before the procedure, all 
patients were receiving oral anticoagulation therapy for ≥1 month, 
and transesophageal echocardiography was performed <48 hours be-
fore the procedure to exclude atrial thrombi.
Surface electrocardiograms and bipolar intracardiac electrograms 
were monitored continuously and stored on a computer-based digital 
amplifier/recorder system (Labsystem Pro; Bard Electrophysiology, 
Lowell, MA). Signals were band pass–filtered as follows: ECGs from 
0.1 to 50 Hz; PV electrograms from 100 to 250 Hz; other intracardiac 
electrograms from 30 to 250 Hz.
The following catheters were introduced through the right femoral 
vein: (1) a steerable decapolar catheter was positioned within the cor-
onary sinus; (2) a 10-pole circumferential catheter (Lasso; Biosense 
Webster, Diamond Bar, CA) was used for PV mapping; and (3) a 3.5-
mm externally irrigated tip ablation catheter (Biosense Webster). The 
Lasso was stabilized with a long sheath (SLO; St Jude Medical, St 
Paul, MN) perfused continuously with heparinized solution. A single 
bolus of 50 IU/kg heparin was administered immediately after trans-
septal puncture. The activated clotting time was maintained thereafter 
within a range of 250 to 300 seconds.
Ablation Procedure for Persistent AF
In all patients, sequential stepwise ablation was performed as pre-
viously described.2 In brief, as the first step, PVI was performed 
using contiguous circumferential lesions around ipsilateral PVs. 
Electrogram-guided LA ablation was then performed and targeted 
sites displaying complex electrogram features: continuous electric 
activity, complex fractionated electrograms, locally short AF CL, and 
sites with a gradient of activation. When ablation of the inferior LA 
did not result in organization of the coronary sinus, additional abla-
tion within the coronary sinus was performed. Linear LA ablation 
was performed if AF persisted and targeted the LA roof followed 
by the mitral isthmus, with the end point of significant reduction or 
abolition of local electrograms. In the presence of shorter AF CL in 
the right atrium, electrogram-guided ablation was performed in that 
chamber using the same criteria as in the LA. Cavotricuspid isthmus 
ablation was performed in most patients. After restoration of sinus 
rhythm, PVI and conduction across all the deployed linear lesions 
were checked. Additional radiofrequency applications to achieve PVI 
and complete linear conduction block were undertaken, if required.
Procedural End Point
The procedural end point was termination of AF by catheter abla-
tion to either a sustained atrial tachycardia (AT) or directly to sinus 
rhythm (AF termination group). If AF converted into AT, ablation was 
performed until the restoration of sinus rhythm. If termination was 
not achieved by the stepwise ablation approach, electric cardioversion 
was performed to restore sinus rhythm, and the patient was assigned 
to the AF nontermination group (procedural failure).
PV Activity and AF CL Measurement
PV activity during AF was analyzed with respect to the LA AF CL 
assessed from the intracardiac recording of the LA appendage (LAA) 
immediately after transseptal access.10 The mean LAA AF CL was 
first measured manually with online calipers by averaging 100 con-
secutive cycles to ensure accurate and reproducible measurements.
The CL of PV activity was then assessed from the recordings ob-
tained with the 10-pole circumferential mapping catheter (Lasso) be-
fore ablation. Sequential recordings were made from each of the 4 
PVs. Analysis was made by a cardiologist blinded to the clinical and 
procedural information. For each PV, both the mean CL and CL of the 
fastest recorded PV activation were assessed. The mean CL was ob-
tained by averaging 100 consecutive cycles measured manually with 
online calipers from a preablation sample. Regarding the recording 
of the shortest PV CL, an observation window of 1 minute was cho-
sen considering the previously reported periodicity of the intermittent 
burst of fast PV activity.7,8 The time interval between each PV signal 
was measured at a sweep speed of 100 mm per second using electron-
ic calipers. In the event of beat-to-beat changes in the PV activation, 
double potentials, or when the interpotential delays were not uniform 
along the Lasso bipoles, the PV CL was defined as the delay between 
the earliest potentials of 2 successive PV breakthroughs (Figure 1A). 
When depolarizations of >1 overlapping muscle fascicle were simul-
taneously recorded at some segments of the PV ostia, care was taken 
to identify each fascicle activity by comparing the activation patterns 
recorded at adjacent sites (Figure 1B). In such cases, the shortest CL 
of each fascicle was considered for analysis. To derive the maximum 
difference in CL between PVs and the LA AF CL, the lowest value 
of the 4 PVs was considered for analysis for both the mean CL and 
the CL of the fastest PV activation (PV
mean
 and PVfast, respectively). 
The CL gradient between the PV and the LA was quantified by the 
computing the ratio of the PV CL divided by the LAA CL.
Follow-Up
All patients were monitored in hospital for 3 to 5 days postprocedure. 
Antiarrhythmic drugs (AADs) were discontinued 3 months after the 
index procedure in the absence of a continued indication. Patients 
were re-evaluated at 1, 3, 6, 9, and 12 months, and in the absence 
of AF or symptoms, followed up with their referring physician. At 
each visit, ambulatory 24- to 48-hour monitoring was performed to 
detect asymptomatic arrhythmias. One year from the last procedure, 
patients were seen every 6 months by their referring cardiologist. 
All patients underwent 24-hour Holter monitoring within the last 3 
months of follow-up. In the event of arrhythmia recurrence, patients 
were offered a trial of drug therapy and then additional ablation. As 
for the index procedure, the sequential stepwise ablation was per-
formed with the end point of AF termination.
Clinical Outcome
Success after first procedure was defined as maintenance of sinus 
rhythm (absence of symptomatic and asymptomatic AF or AT) dur-
ing follow-up after the index ablation, with a postprocedural blanking 
period of 3 months. Success after the last procedure was defined as 
maintenance of sinus rhythm after the last ablation with or without 
AADs with a postprocedural blanking period of 3 months.
Statistical Analysis
Continuous variables are presented as arithmetic means±SD or medi-
an with interquartile range where indicated. Categorical variables are 
expressed as absolute numbers and percentages. Categorical variables 
were compared with the χ2 test or the Fisher exact test, and continu-
ous variables with the unpaired Student t test or the Mann–Whitney 
test, as appropriate. One-way ANOVA test was used to compare values 
between groups categorized according to the extent of substrate-based 
ablation needed to terminate AF. Diagnostic performance of predictors 
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of AF termination was evaluated by receiver-operator characteristic 
analysis. The optimal cutpoint was chosen as the combination with 
the highest sensitivity and specificity. To analyze independent predic-
tive factors of AF termination during ablation, and independent factors 
of clinical success, univariate factors presenting a P value <0.1 were 
analyzed using logistic regression (multivariate analysis). Candidate 
covariates for adjustment were age, duration of continuous AF, LA 
dimensions, structural heart disease, ejection fraction, hypertension, 
and amiodarone use. Cumulative event rates (recurrence of arrhyth-
mia) were calculated according to the Kaplan–Meier method, and 
the log-rank test was used to detect significant differences between 
groups. All tests were 2-tailed, and statistical significance was as-
sumed for P values <0.05. Statistical analysis was performed using 
the software SPSS, 17.0 (SPSS, Inc, Chicago, IL).
Results
A total of 97 consecutive patients were studied. The base-
line characteristics of the patient population are presented in 
Table 1.The mean age was 58±11 years and 81% were men. 
Figure 1. Measurement of the PV activity CL in changing (A) or complex (B) activation patterns. A, Tracing of a change in the activation 
pattern between the second and the third beat recorded by the Lasso catheter positioned in left inferior PV. The PV CL is defined as the 
delay between the earliest activation of the 2 successive PV breakthroughs (arrows; 140 ms). B, Simultaneous recording of >1 PV muscle 
fascicle on the Lasso catheter positioned in the right inferior PV. The shortest delay between 2 successive PV breakthroughs in this trac-
ing would be 60 ms (between the second and the third beat). However, when comparing the timing and the activation patterns of each PV 
breakthroughs, the activity of 2 distinct overlapping PV fascicles becomes apparent. The first (asterisks) has a stable activation pattern 
(bipole PV 1–2 activated first) with a fairly regular CL of 130 ms, whereas the breakthrough of the second fascicle (dashed circles) occurs at 
bipole PV 5 to 6 with a CL of 230 ms. Of note, if a conventional quadripolar catheter is used to measure electrograms within the PV or if the 
activation patterns recorded on the Lasso are not compared, it is likely that the PV activity CL would have been erroneously measured to 
be 70 ms shorter than the true shortest CL measured on this tracing (ie, 130 ms). CL indicates cycle length; and PV, pulmonary vein.
Table.  Clinical Characteristics of the Study Population
Total (n=97)
AF Termination 
Group (n=73)
AF Nontermination 
Group (n=24) P Value
Age, y 58±11 56±10 64±9 0.001
Male sex, % 81 85 71 0.123
History of AF, mo 74±63 75±66 70±51 0.726
Duration of continuous AF, mo 19±21 16±17 28±28 0.025
Long-lasting persistent AF, % 58 53 71 0.134
LVEF, % 56±14 56±13 53±15 0.363
LV dysfunction (LVEF <50%), % 26 25 29 0.661
LA diameter, mm 46±7 46±7 48±7 0.128
Hypertension, % 41 37 54 0.138
Structural heart disease, % 40 37 50 0.259
Number of failed AAD 1.9±0.9 2.0±0.9 1.9±1.2 0.755
Administration of amiodarone, % 45 41 58 0.141
AAD indicates antiarrhythmic drugs; AF, atrial fibrillation; LA, left atrial; and LVEF, left ventricular ejection 
fraction.
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The mean duration of continuous AF was 19±21 months 
(median, 12 months; interquartile range, 6–24 months).
Procedural Termination of AF
AF was terminated by catheter ablation in 73 of 97 patients 
(75%), whereas in the remaining 24 patients (25%), AF could 
not be terminated and required electric cardioversion. Baseline 
LAA CL was comparable between the termination and nonter-
mination group (156±29 versus 161±24, respectively; P=0.34).
PV Activity of CL and Procedural Termination  
of AF
At baseline, the lowest mean CL of the 4 PVs (PV
mean
) did 
not significantly differ between patients with AF termina-
tion compared with patients without termination (157±27 
versus 166±34 ms; P=0.186; Figure 2A). On the contrary, 
the fastest recorded PV CL (PVfast) was significantly shorter 
in patients with AF termination compared with those in 
whom AF could not be terminated (114±23 versus 143±31 
ms; P<0.001). There was, however, a notable overlap of val-
ues between the 2 groups (Figure 2B). Nonetheless, fast PV 
activities were rarely observed in patients in whom AF could 
not be terminated by ablation. A cut-off value, PVfast ≤110 
ms, predicted AF termination with 95% positive predictive 
value (sensitivity 53%, specificity 92%, negative predic-
tive value 39%). The fastest PV CL was recorded in the left 
superior PV in 39% of patients, the left inferior PV in 24%, 
the right superior PV in 21%, and the right inferior PV in 
15%. Figure 3 displays an example of the baseline LAA and 
PV recordings from a 45-year-old man with continuous AF 
duration of 8 months.
PV to LA CL Gradient and Procedural AF 
Termination
The gradient between the fastest PV activity and the LA AF CL 
(PVfast/LAA ratio) showed a limited overlap of values between 
the AF termination and the nontermination group (Figure 3C). 
In the nontermination group, the PVfast CLs were similar to 
the LAA CLs resulting in a mean PVfast/LAA ratio of 92±7%. 
On the contrary, the PVfast CLs were much shorter than the 
LAA CLs resulting in a significantly lower PVfast/LAA ratio 
(ie, higher gradient) of 71±10% (P<0.001) in the AF termina-
tion group. The receiver-operator characteristic curve analysis 
of the PVfast/LAA ratio yielded an optimal cut-off value ≤85% 
to predict AF termination with an area under the curve of 
0.968 (95% confidence interval [CI], 0.922–1.000; P<0.001; 
Figure 4A). PVfast/LAA ratio ≤85% provided a 96% positive 
predictive value, 91% negative predictive value, 97% sensitiv-
ity, and 88% specificity for AF termination.
Predictors of Procedural AF Termination
The preprocedural clinical variables were compared in 
patients in whom AF terminated by catheter ablation ver-
sus those in whom AF could not be terminated. AF termi-
nation was associated with a younger age (56±10 versus 
64±9 years; P=0.001), a shorter duration of continuous 
AF (16±17 versus 28±28 months; P=0.025), and a nonsig-
nificant trend toward smaller LA dimensions (46±7 versus 
48±7 mm; P=0.13). Using a stepwise logistical regression 
technique incorporating preablation clinical and procedural 
variables, only the PVfast/LAA ratio independently predicted 
AF termination (adjusted odds ratio [OR], 0.691; 95% CI, 
0.580–0.823; P<0.001).
PV to LA CL Gradient: Ablation Time to AF 
Termination and Mode of Termination
AF terminated during PVI in 11 patients (11%), whereas in 
the remaining 62 patients (64%), AF terminated during the 
electrogram-guided or linear ablation steps. In the latter 
group, the additional (after PVI) procedural and ablation times 
were 64±43 minutes (median, 54; interquartile range, 30–90) 
and 34±21 minutes (median, 30; interquartile range, 19–45), 
respectively.
In the AF termination group, the PVfast/LAA ratio was com-
pared between patients in whom AF terminated during PVI 
(PVI term) versus those who required adjunctive substrate-
based ablation to terminate AF. The extent of substrate-based 
ablation was further categorized according to the quartiles of 
ablation time needed to terminate AF after completion of PVI. 
Limited or extensive substrate-based ablation was defined as 
the lowest and highest quartiles, whereas moderate ablation 
was defined as the interquartile range of ablation time. In 
patients with AF termination during PVI, the PVfast CLs were 
much shorter than the LA AF CL with a mean PVfast/LAA ratio 
of 63±6% (Figure 5). A similar PV to LA CL gradient was 
found in the group of patients with AF termination after lim-
ited substrate ablation (PVfast/LAA ratio, 63±6%; P=0.995). 
In both groups, the PVfast/LAA ratios were notably lower com-
pared with that in the patients where moderate or extensive 
substrate ablation was required. The mean PVfast/LAA ratio 
was 74±8% in patients with AF termination after moderate 
substrate ablation (P=0.001 versus PVI term and P<0.001 ver-
sus limited substrate ablation) and 79±7% in those with AF 
termination after extensive substrate ablation (P<0.001 versus 
each of PVI term and limited substrate ablation). The receiver-
operator characteristic curve analysis to discriminate patients 
with AF termination after PVI or limited substrate ablation 
from those who required more substantial ablation yielded an 
optimal cut-off value <69% with an area under the curve of 
0.921 (95% CI, 0.867–0.975; P<0.001; Figure 4B). A PVfast/
LAA ratio <69% provided a 74% positive predictive value, 
95% negative predictive value, 88% sensitivity, and 89% 
specificity for AF termination after PVI or limited additional 
substrate ablation.
The PV to LA CL gradient was also evaluated with respect 
to the mode of AF termination. AF terminated via an interme-
diate step of AT in 52 patients (71%) and directly into sinus 
rhythm in the remaining 21 (29%). Termination into sinus 
rhythm was associated with significantly lower PVfast/LAA 
ratios when compared with termination into an AT (66±10% 
versus 73±9%; P=0.005).
Predictors of AF Termination After PVI or Limited 
Substrate Ablation
The preprocedural clinical variables were compared between 
patients in whom AF terminated after PVI or limited additional 
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substrate ablation and those who required more than lim-
ited substrate ablation to terminate AF. AF termination with 
no or limited substrate ablation was associated with younger 
age (53±9 versus 60±11 years; P=0.014), shorter duration of 
continuous AF (10±8 versus 22±23 months; P=0.016), and 
lower prevalence of structural heart disease (19% versus 48%; 
P=0.014). In the multivariate analysis incorporating preabla-
tion clinical and procedural variables, both the PVfast/LAA 
ratio (adjusted OR, 0.772; 95% CI, 0.688–0.866; P<0.001) 
and the presence of structural heart disease (adjusted OR, 
0.071; 95% CI, 0.012–0.438; P=0.004) independently pre-
dicted termination of AF with PVI only or limited additional 
substrate ablation.
Follow-Up and Clinical Outcome
Two patients were lost to follow-up after the initial procedure. 
After a mean follow-up of 36±18 months, freedom from atrial 
arrhythmia was achieved in 34 patients (36%) after a single 
ablation procedure with or without AADs. Among the patients 
who presented with recurrent arrhythmia, 38% were in persis-
tent AF, 12% in paroxysmal AF, and the remaining 50% were 
in AT (persistent or paroxysmal). Recurrence in persistent AF 
was more often observed in the nontermination group com-
pared with the termination group (52% versus 18%; P=0.001).
A repeat ablation procedure was performed in 41 out of 61 
patients with arrhythmia recurrence. Ten patients underwent 
>2 procedures. After 1.6±0.7 procedures and a mean follow-
up of 29±17 months from the last procedure, the overall 
success rate was 71% (including 21% on AADs; n=20). Long-
term clinical success was higher in patients with AF termi-
nation during the index procedure (81%; 28% taking AADs) 
compared with the nontermination group (39%; P<0.001; 
44% taking AADs).
PV Activity to LA CL Gradient and Long-Term 
Clinical Outcome
In patients with a PVfast/LAA ratio >85%, freedom from atrial 
arrhythmias after the last procedure was achieved only in 41% 
Figure 2. Scatterplot showing the individual values of (A) the mean PV CL (PVmean), (B) the fastest PV CL (PVfast), and (C) the PVfast to left 
atrial AF CL gradient (PVfast/LAA ratio) in patients with and without procedural AF termination. Horizontal line indicates optimal diagnostic 
cut-off values to predict AF termination. AF indicates atrial fibrillation; CL, cycle length; LAA, left atrial appendage; and PV, pulmonary vein.
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of cases (44% taking AADs) against 80% (29% taking AADs) 
in patients with a ratio ≤85% (P<0.001).
With regard to the subgroup of patients with PVfast/LAA 
ratio <69%, the arrhythmia-free survival after the last proce-
dure with or without AADs was superior when compared with 
the remaining population (84% versus 64%; P=0.049). A ratio 
<69% provided additional outcome stratification over an 85% 
cut-off as, among the patients without arrhythmia recurrence, 
only 8% were on AADs compared with 44% in the subgroup 
with a 69% to 85% PVfast/LAA ratio (P=0.002). Therefore, 
even among the patients with a more favorable outcome (ie, 
with PVfast/LAA ratio ≤85%), a higher clinical success rate 
off-AADs was observed in patients with a ratio <69% com-
pared with those with a 69% to 85% ratio (80% versus 55%; 
Figure 3. Baseline tracings of the LAA and 4 PVs from a 45-year-old man with continuous AF for 8 months. Left, The fastest recorded PV 
activities observed over a 1-min observation window are illustrated for each vein. Far-field LAA activity is apparent in the left superior PV 
(asterisks). Rapid PV activities are observed in all 4 PVs, the fastest being recorded in the left inferior PV (PVfast, 82 ms). Of note, these fast 
activities occur as intermittent bursts that are separated by slow PV rhythm (slower than the LAA AF CL). The mean PV CLs (averaged on 
100 beats) are lowest in the right superior PV (PVmean, 154 ms). Although no gradient of CL is observed between the PVmean and the LAA 
CL, the PVfast CL is much lower than the LAA CL (PVfast/LAA ratio, 57%). The high PV to LAA CL gradient alternating with periods of slow 
PV rhythm (gradient inversion) both suggested intermittent active PV firing. Right, Catheter ablation terminated AF after PV isolation, dur-
ing the second min of radiofrequency application for adjunctive substrate-based ablation. AF indicates atrial fibrillation; CL, cycle length; 
LAA, left atrial appendage; and PV, pulmonary vein.
Figure 4. Procedural outcome according to the PVfast to left atrial AF CL gradient. Receiver-operating characteristic curve analysis of the 
PVfast/LAA ratio to predict (A) AF termination during stepwise ablation and (B) AF termination with only PV isolation or limited substrate-
based ablation (first quartile of ablation time). Arrows show optimal cut-off point for sensitivity and specificity. AF indicates atrial fibrilla-
tion; CI, confidence interval; CL, cycle length; LAA, left atrial appendage; and PV, pulmonary vein.
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P=0.032). Also, among the patients with arrhythmia recur-
rence, paroxysmal forms of AF were more often observed in 
the subgroup with PVfast/LAA ratio <69% than in the rest of 
the study population (25% versus 6%; P=0.032; Figure 6). 
Figure 7 displays Kaplan–Meier arrhythmia-free survival 
curves stratified according to PVfast/LAA cut-off values.
Predictors of Success After the Last  
Ablation Procedure
In comparison with the patients with recurrent arrhythmias, 
patients who remained in stable sinus rhythm after the last 
procedure were younger (56±10 versus 63±9 years; P=0.002), 
had lower LA dimension (45±6 versus 50±7 mm; P=0.003), 
Figure 5. Boxplot showing the values of the PVfast 
to left atrial AF CL gradient (PVfast/LAA ratio) in 
patients with AF termination achieved during PV 
isolation versus substrate-based ablation. The 
extent of substrate ablation is categorized as lim-
ited, moderate, and extensive according to the 
quartiles of ablation time needed to terminate AF 
after completion of PV isolation. AF indicates atrial 
fibrillation; CL, cycle length; LAA, left atrial append-
age; and PV, pulmonary vein.
Figure 6. Tracings from a 40-year-old man with continuous AF for 12 months recorded during the index procedure (left) and the repeat 
procedure 3 years later for paroxysmal AF recurrence (right). Left, At baseline, fast PV activities are recorded in all 4 PVs with a high gra-
dient between the fastest PV activity and the LA AF CL (PVfast/LAA ratio, 68%). AF terminated after PV isolation and 21 min of additional 
radiofrequency application for substrate-based ablation. At the repeat procedure, reisolation of 3 reconnected PVs was performed in 
sinus rhythm (right). Right, Subsequently, intermittent bursts of fast PV activities with exit block were observed in 2 of them. Isoproter-
enol and rapid burst pacing failed to induce AF afterward. The mode of recurrence and the demonstration of active PV firing provided a 
late confirmation that a trigger-based mechanism was contributing to AF persistence as initially suspected based on the low PVfast/LAA 
ratio. AF indicates atrial fibrillation; CL, cycle length; LAA, left atrial appendage; and PV, pulmonary vein.
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and a trend toward shorter duration of continuous AF (16±17 
versus 26±28 months; P=0.056). In the multivariate analysis 
incorporating preablation clinical and procedural variables, 
both the PVfast/LAA ratio (adjusted OR, 0.939; 95% CI, 
0.899–0.981; P=0.004) and the LA dimension (adjusted OR, 
0.905; 95% CI, 0.840–0.974; P=0.008) independently pre-
dicted long-term freedom from recurrent arrhythmia.
Discussion
Main Findings
The present study evaluated whether the analysis of the PV 
activity in relation to the atrial AF CL could help stratify the 
procedural and long-term outcome of patients undergoing per-
sistent AF ablation. The major findings of this study are: (1) 
the occurrence of intermittent rapid activity within the PVs, 
but not their mean CL, helps characterize the contribution of 
PVs to the maintenance of persistent AF; (2) a high CL gradi-
ent between the fastest recorded PV activity and the AF CL 
(PVfast/LAA ratio <69%) identifies patients in whom AF is 
likely to terminate after PVI or limited additional substrate 
ablation; (3) the absence of substantial gradient between the 
fastest PV activity and the AF CL (PVfast/LAA ratio >85%) 
identifies patients in whom AF is unlikely to terminate by 
ablation and the long-term success is limited.
Markers and Role of PV Activity in Persistent AF
There has been an accumulating body of evidence demonstrat-
ing that PVs play an important role in a subset of patients with 
persistent AF. Our group previously showed that the PVs were 
the dominant triggers reinitiating chronic AF after cardiover-
sion (94%), and their ablation resulted in sinus rhythm main-
tenance in a significant proportion of patients. More recently, 
Inoue et al5 observed reproducible immediate recurrences of 
AF after cardioversion in 27% of 263 patients with persistent 
AF. The triggers reinitiating AF originated mostly from the 
PVs (81%). The role of the reinitiating triggers in the per-
sistence of AF was demonstrated by the strong influence of 
their successful elimination on clinical outcome. These find-
ings support the hypothesis that PV activity may be elevated 
enough to trigger repetitive paroxysmal AF episodes before 
the preceding one terminates leading to persistent AF. The 
role of PV is further supported by the evidence that a sub-
stantial proportion of patients can achieve stable long-term 
sinus rhythm off-AAD after PVI only even in longstanding 
persistent AF.11,12 The challenge however remains to identify 
during ongoing AF that subgroup of patients with persistent 
AF where PVs play a major role. Previous studies including 
mostly patients with paroxysmal AF have shown that inter-
mittent rapid PV activities during sustained AF were recorded 
from the same PVs that exhibited arrhythmogenic foci that 
triggered AF during sinus rhythm.7 The likelihood of inducing 
persistent AF by rapid pacing was markedly diminished after 
the elimination of the intermittent bursts of PV tachycardia. 
Moreover, the probability of AF termination during isola-
tion of a PV was directly related to the extent of tachycardia 
recorded in that vein.6,8 These observations suggest that the 
PVs are not only a source of the triggers that initiate AF but 
may also have a role in the maintenance of AF. This has been 
further corroborated by the observation that isolation of each 
PV in patients with sustained paroxysmal AF episodes was 
associated with a gradual slowing of the fibrillatory process 
that culminated in the termination of AF.13 Intermittent bursts 
of PV tachycardia may maintain AF in the same way as inter-
mittent bursts of rapid pacing do prevent the tendency toward 
spontaneous conversion of experimental pacing induced AF.14
PV Activity to LA AF CL Gradient Provides 
Mechanistic Insights Into the Mechanism of 
Persistent AF
Our study shows that the observations made previously during 
sustained paroxysmal AF can also be extended to persistent 
Figure 7. Kaplan–Meier curves of the arrhythmia-free survival after the last procedure for (A) the entire population and (B) the population 
off-AADs. Patients are stratified according to the baseline PVfast/LAA ratio. AAD indicates antiarrhythmic drug; AF, atrial fibrillation; CL, 
cycle length; LAA, left atrial appendage; and PV, pulmonary vein.
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AF. We could demonstrate that the recording of a significant 
CL gradient between PV activity and the LA AF CL allowed 
to discriminate patients whose AF was likely to terminate with 
PVI only or limited additional substrate ablation. Moreover, 
long-term freedom from arrhythmia recurrence was achieved 
in most of these patients as opposed to the rest of the study 
population. Also, both termination of AF directly to sinus 
rhythm and recurrences in paroxysmal AF were more often 
observed. Both findings further suggest a trigger-dependent 
mechanism of AF persistence as opposed to one based on 
advanced changes in the substrate.
On the contrary, the absence of a significant gradient 
between the fastest PV and the AF CL pointed toward pas-
sive PV activity. Indeed, we observed that procedural AF ter-
mination could not be achieved in most of these patients or 
required extensive substrate modification. A passive role of 
PVs was further suggested by the limited long-term success 
rate achieved despite PVI. In these patients, the mechanism 
underlying AF persistence was likely attributable to advanced 
atrial substrate changes.
Role of PV in Patients With AF Termination After 
Limited Additional Substrate Ablation
It is usually considered that termination of AF after limited 
additional defragmentation is a direct effect of the early iden-
tification of critical AF targets located outside the PVs. How-
ever, these patients could be specifically discriminated from 
the rest of the study population based on the identification of 
rapid PV rhythms in the same way as those with AF termina-
tion during PVI. Therefore, our findings reinforce the major 
role of PVs in these patients although limited substrate-based 
modification could still be required to achieve AF termination.
It has been shown experimentally that the longer AF has 
been present for, the longer artificially induced AF paroxysms 
last.14 Therefore, one can reasonably assume that in persistent 
forms of AF, a certain period of latency is likely before AF ter-
minates once critical targets have been ablated. This may also 
explain why AF failed to terminate during PVI in some of the 
patients with a high PV to LA CL gradient. Consistent with 
the latency assumption is the observation that sinus rhythm 
restoration occurred well after the cessation of radiofrequency 
application rather than during ongoing ablation in more than 
one third of the study population (37%). These considerations 
raise the question whether adjunctive substrate-based ablation 
was indeed warranted to achieve similar long-term outcome in 
patients demonstrating high PV to LA CL gradients.
Importance of Sampling Time During PV Activity 
Evaluation
Studies performing spectral analysis and frequency mapping 
during AF have demonstrated the ability to localize the sites 
of rapid and periodic activity closely linked to the sources that 
maintain AF.15–18 These studies consistently demonstrated that 
these dominant frequency sources of activity often emanated 
from the PV region in paroxysmal AF.15,19–21 On the contrary, 
in patients with persistent AF, the PVs were less likely to har-
bor sites of high frequency. However, these studies were based 
on recordings of a few seconds or averaged in sliding win-
dows over 20 to 30 seconds. The assumed temporal stability of 
the AF activity underlying this methodology is challenged by 
our findings. Our data indicate that the occurrence of intermit-
tent rapid activity within the PVs, but not their average CL, 
could help characterize their contribution to AF persistence. 
The assessment of the fastest recorded PV activity over a 
1-minute observation window allowed to detect these episodic 
burst phenomena that would have otherwise been missed with 
shorter or averaged recording intervals. The periodicity of 
these rapid repetitive activities may be as low as 1 per minute 
and they may occur in temporal clusters of less than few sec-
onds.7,8 It is plausible that longer recording intervals may be 
required in remodeled atria with persistent AF where less fre-
quent rapid PV activity may suffice to sustain AF as opposed 
to paroxysmal AF episodes where more constant refueling of 
the fibrillatory process is required.
Study Limitations
This study primarily makes a novel observation and infers a 
causal link between intermittent rapid PV activities and AF 
maintenance based on the ablation outcome. However, the 
assumption that these rapid PV activities actually represented 
an active phenomenon was not systematically demonstrated 
by the simultaneous recording of a slower AF CL in the adja-
cent LA. It is possible that these rapid rhythms were some-
times caused by fractionation of wavefronts entering the PV 
from the LA instead of by paroxysmal burst of tachycardia 
generated within the vein.
Moreover, although a relationship between rapid PV 
rhythms and ablation outcome was demonstrated, their role 
has not been established by this observational study. Whether 
these repetitive activities act as triggers of AF or contrib-
ute to sustain episodes triggered outside PVs remains to be 
determined.
Conclusions
An attentive monitoring of the PV activity in relation to the 
atrial AF CL may discriminate patients in whom AF is likely 
to terminate after PVI or limited substrate ablation from those 
in whom AF is unlikely to terminate by ablation and long-
term success is limited. By providing the tool to identify the 
subset of patients where PVs still play an important role in AF 
persistence, these findings may be a step toward more tailored 
ablation strategies.
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CLINICAL PERSPECTIVE
Pulmonary vein (PV) triggers play a major role in the initiation of atrial fibrillation (AF), and PV isolation is the cornerstone 
of catheter ablation for paroxysmal AF. The success of this approach is limited in nonparoxysmal forms of AF, and adjunc-
tive ablation strategies have been developed to target the alterations in the underlying substrate that may perpetuate AF. 
Nonetheless, the mechanisms underlying AF persistence are not uniform, and a trigger-based mechanism may be operative 
in a subset of patients. Identifying these patients remains a challenge. Intermittent rapid rhythms arising in the PVs are com-
monly observed during sustained episodes of paroxysmal AF. These rapid activities represent an active phenomenon that 
may have a critical role in the maintenance of AF by providing continued refueling of the fibrillatory process. We therefore 
evaluated in persistent AF the cycle length gradient between PVs and the left atrium in an attempt to identify patients where 
PVs play an important role. Our study demonstrates that an attentive monitoring of the PV activity in relation to the atrial 
AF CL may discriminate patients in whom AF is likely to terminate after PV isolation or limited substrate ablation from 
those in whom AF is unlikely to terminate by ablation and long-term success is limited. By providing the tool to identify the 
subset of patients in whom the PVs still play an important role in AF persistence, these findings may be a step toward more 
tailored ablation strategies.
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